"Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial" by Faramarz Ismail-Beigi

Article

Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial

The Lancet (2010)

Faramarz Ismail-Beigi, Case Western Reserve University
Timothy Craven, Wake Forest University
Mary Ann Banerji, SUNY Downstate Medical Center
Jan Basile, Medical University of South Carolina
Jorge Calles, Wake Forest Baptist Medical Center
Robert M Cohen, University of Cincinnati
Robert Cuddihy, University of Minnesota
William C Cushman, University of Tennessee Health Science Center
Saul Genuth, Case Western Reserve University
Richard H Grimm, University of Minnesota
Bruce P Hamilton, University of Maryland, Baltimore
Byron Hoogwerf, Eli Lilly and Company
Diane Karl, Oregon Health & Science University
Lois Katz, New York University
Armand Krikorian, Case Western Reserve University
Patrick O'Connor, HealthPartners
Rodica Pop-Busui, University of Michigan
Ulrich Schubart, Albert Einstein College of Medicine
Debra Simmons, University of Arkansas for Medical Sciences
Harris Taylor, Case Western Reserve University
Abraham Thomas, Henry Ford Hospital
Daniel Weiss, University of Oxford
Irene Hramiak, University of Western Ontario

Link

Disciplines

Publication Date

January 8, 2010

DOI

10.1016/S0140-6736(10)60576-4

Citation Information

Faramarz Ismail-Beigi, Timothy Craven, Mary Ann Banerji, Jan Basile, et al.. "Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial" The Lancet Vol. 376 Iss. 9739 (2010) p. 419 - 430
Available at: http://works.bepress.com/abraham-thomas/28/